DaVita Price to Book Ratio 2010-2024 | DVA

Historical price to book ratio values for DaVita (DVA) over the last 10 years. The current price to book ratio for DaVita as of November 07, 2024 is 21.02.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

DaVita Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-11-06 147.07 20.71
2024-09-30 163.93 $7.10 23.09
2024-06-30 138.57 $9.99 13.87
2024-03-31 138.05 $12.91 10.69
2023-12-31 104.76 $14.01 7.48
2023-09-30 94.53 $15.10 6.26
2023-06-30 100.47 $13.21 7.60
2023-03-31 81.11 $11.25 7.21
2022-12-31 74.67 $9.69 7.71
2022-09-30 82.77 $7.79 10.62
2022-06-30 79.96 $8.41 9.51
2022-03-31 113.11 $10.69 10.58
2021-12-31 113.76 $9.62 11.82
2021-09-30 116.26 $12.88 9.03
2021-06-30 120.43 $13.85 8.70
2020-12-31 117.40 $14.25 8.24
2020-09-30 85.65 $15.41 5.56
2020-06-30 79.14 $19.13 4.14
2020-03-31 76.06 $17.51 4.34
2019-12-31 75.03 $18.43 4.07
2021-03-31 107.77 $13.38 8.05
2019-09-30 57.07 $18.77 3.04
2019-06-30 56.26 $25.80 2.18
2019-03-31 54.29 $24.56 2.21
2018-12-31 51.46 $23.49 2.19
2018-09-30 71.63 $24.28 2.95
2018-06-30 69.44 $26.25 2.65
2018-03-31 65.94 $26.80 2.46
2017-12-31 72.25 $26.78 2.70
2017-09-30 59.39 $26.26 2.26
2017-06-30 64.76 $27.57 2.35
2017-03-31 67.97 $27.44 2.48
2016-12-31 64.20 $24.93 2.58
2016-09-30 66.07 $25.50 2.59
2016-06-30 77.32 $23.97 3.23
2016-03-31 73.38 $23.85 3.08
2015-12-31 69.71 $24.24 2.88
2015-09-30 72.33 $24.61 2.94
2015-06-30 79.47 $24.82 3.20
2015-03-31 81.28 $24.04 3.38
2014-12-31 75.74 $24.86 3.05
2014-09-30 73.14 $23.97 3.05
2014-06-30 72.32 $23.08 3.13
2014-03-31 68.85 $22.60 3.05
2013-12-31 63.37 $21.61 2.93
2013-09-30 56.90 $20.87 2.73
2013-06-30 60.40 $20.15 3.00
2013-03-31 59.30 $18.72 3.17
2012-12-31 55.27 $18.56 2.98
2012-09-30 51.81 $14.00 3.70
2012-06-30 49.11 $13.27 3.70
2012-03-31 45.09 $12.78 3.53
2011-12-31 37.91 $12.11 3.13
2011-09-30 31.34 $11.14 2.81
2011-06-30 43.31 $10.41 4.16
2011-03-31 42.76 $11.08 3.86
2010-12-31 34.75 $10.61 3.27
2010-09-30 34.52 $11.73 2.94
2010-06-30 31.22 $11.49 2.72
2009-12-31 29.37 $10.64 2.76
2009-09-30 28.32 $10.36 2.73
2009-06-30 24.73 $9.89 2.50
2009-03-31 21.98 $9.30 2.36
2010-03-31 31.70 $11.17 2.84
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.330B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.553B 12.43
Quest Diagnostics (DGX) United States $17.434B 17.67
Encompass Health (EHC) United States $10.431B 24.59
Chemed (CHE) United States $8.349B 25.66
Elanco Animal Health (ELAN) United States $7.168B 17.06
RadNet (RDNT) United States $5.281B 125.26
Option Care Health (OPCH) United States $3.902B 18.49
Amedisys (AMED) United States $3.169B 22.56
LifeStance Health (LFST) United States $2.939B 0.00
Astrana Health (ASTH) United States $2.900B 45.45
Addus HomeCare (ADUS) United States $2.341B 27.46
U.S Physical Therapy (USPH) United States $1.436B 37.81
Pennant (PNTG) United States $1.099B 44.44
Aveanna Healthcare Holdings (AVAH) United States $1.080B 0.00
Atai Life Sciences (ATAI) Germany $0.227B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00